Purpose: Repairing damaged DNA has been shown to be involved in an increased susceptibility to cancer development and prevention. Therefore, the genetic polymorphisms of the hOGG1 gene associated with the gene repair mechanism were investigated. In this study, the possible association of genetic polymorphisms in hOGG1 with bladder tumor risk was examined. MATERIALS AND METHODS: The hospital based, case-control investigation was carried out in 168 primary bladder tumor patients and 672 controls. The DNA extracted from the blood and tissue samples was analyzed by SSCP, PCR-based restriction fragment length polymorphism (RFLP) and direct DNA sequencing in order to characterize the genetic polymorphism of hOGG1. RESULTS: Two polymorphic sites in hOGG1 were found. A polymorphism at codon 326 (1a type) in exon 7 was associated with an amino acid exchange. Another polymorphic site at codon 324 (1b type) in exon 6 was silent. The association between the polymorphism at codon 326 and the risk of the bladder tumor was examined by age-sex adjusted analysis. The distribution of the hOGG1 codon 326 genotypes in the controls (Ser/Ser, 18.9%; Ser/Cys, 54.0%; Cys/Cys, 27.1%) was significantly different from that in the bladder tumor patients (26.2%, 51.8% and 22.0%, respectively) (p=0.034, adjusted OR=0.652, 95% CI=0.44-0.97). In particular, bladder tumor risk in Korean males under 40 years old was approximately 6 times higher than in males over 40 years old (p=0.015, adjusted OR=0.165, 95% CI=0.04-0.75). Furthermore, frequent mutations of codon 326 in the hOGG1 gene in tumor tissues (23.6%) might occur during tumorigenesis. CONCLUSIONS: The data suggests that polymorphism at codon 326 of hOGG1 gene might affect tumorigenesis of a bladder tumor.
Adult ; Carcinogenesis ; Case-Control Studies ; Codon ; DNA ; Exons ; Genotype ; Humans* ; Male ; Polymorphism, Genetic ; Polymorphism, Restriction Fragment Length ; Polymorphism, Single-Stranded Conformational ; Sequence Analysis, DNA ; Urinary Bladder Neoplasms* ; Urinary Bladder*

BACKGROUND: Postmenopausal status is associated with a 60% increased risk for metabolic syndrome. It is thought to be associated with decreased estrogens and increased abdominal obesity in postmenopausal women with metabolic syndrome. The purpose of this study was to investigate the association between metabolic syndrome components and menopausal status. METHODS: A total of 1,926 women were studied and divided into three groups according to their menstrual stage (premenopausal, perimenopausal or postmenopausal). The presence of metabolic syndrome was assessed using the National Cholesterol Education Program's (NCEP) Adult Treatment Panel III criteria. RESULTS: The prevalence of metabolic syndrome was 7.1% in premenopause, 9.8% in perimenopause, and 24.2% in postmenopause. The strong correlation was noted between the metabolic syndrome score and waist circumference in postmenopause (r = 0.56, P < 0.01) and perimenopause (r = 0.60, P < 0.01). Along the menopausal transition, the risk of metabolic syndrome increased with high triglyceride after the age-adjusted (odds ratio (OR) 1.517 [95% confidence interval (CI) 1.014~2.269] in perimenopausal women and OR 1.573 [95% CI 1.025~2.414] in postmenopausal women). In addition, the prevalence of metabolic syndromeincreased in accordance with elevated alanine aminotransferase (ALT) and gamma-glutamyl transpeptidase (GGT) levels. CONCLUSION: Triglyceride and waist circumference were important metabolic syndrome components, though ALT and GGT may also be related for predicting metabolic syndrome during the transition to menopause.
Adult ; Alanine Transaminase ; Cholesterol ; Estrogens ; Female ; gamma-Glutamyltransferase ; Humans ; Menopause ; Obesity, Abdominal ; Perimenopause ; Postmenopause ; Premenopause ; Prevalence ; Waist Circumference

Sarcoidosis is a multisystemic granulomatous disease with an of unknown etiology, involving bilateral hilar lymphadenopathy, pulmonary, skin and eye lesions. However, involvement of the endocrine system in sarcoidosis is quite rare, and the coexistence of both diseases is extremely unusual. We describe a 60-year-old woman presenting with sarcoidosis and Graves' disease. She was admitted for evaluation of dry cough, dyspnea, palpitation and general weakness. Both thyroid glands were enlarged diffusely. The thyroid function tests showed suppressed serum thyrotropin and an increased thyroid hormone level. The levels of the TSH receptor antibody, anti-thyroglobulin antibody and anti-microsomal antibody were higher than normal. The radionuclide scan(131I) showed increased iodine uptake. The chest X-ray revealed pulmonary hilar enlargement and high resolution CT showed both hilar lymph nodes enlargement and tiny parenchymal nodules. The transbronchial lung biopsy showed a noncaseating granuloma without necrosis. We report this case of pulmonary sarcoidosis plus Graves' disease with a review of the relevant literatures.
Biopsy ; Cough ; Dyspnea ; Endocrine System ; Female ; Granuloma ; Graves Disease* ; Humans ; Hyperthyroidism ; Iodine ; Lung ; Lymph Nodes ; Lymphatic Diseases ; Middle Aged ; Necrosis ; Receptors, Thyrotropin ; Sarcoidosis ; Sarcoidosis, Pulmonary* ; Skin ; Thorax ; Thyroid Function Tests ; Thyroid Gland ; Thyrotropin

MEN IIa is the rare disorder consisted of thyroid medullary carcinoma, pheochromocytoma, and hyperparathyroidism. We experienced the case in which 42 year-old male patient with thyroid medullary carcinoma and pheochromocytoma complicated by acute myocardial infarction. During the process of conventional treatment of acute myocardial infarction, paroxysmal hypertension occurred for several times. We sought for the cause of paroxysmal hypertension, and found pheochromocytoma by the radiologic imaging study and the biochemical study and we found the 4X4 cm sized neck mass by palpation. After stabilizing his blood pressure by the use of phenoxybenzamine, we removed the pheochromocytoma in right adrenal gland and the medullary thyroid cancer, by right adrenalectomy and total thyroidectomy respectively. Thereafter, his subjective symptoms and objective signs were improved. We report the case with review of literatures.
Adrenal Glands ; Adrenalectomy ; Adult ; Blood Pressure ; Carcinoma, Medullary ; Humans ; Hyperparathyroidism ; Hypertension ; Male ; Multiple Endocrine Neoplasia Type 2a ; Multiple Endocrine Neoplasia* ; Myocardial Infarction* ; Neck ; Palpation ; Phenoxybenzamine ; Pheochromocytoma ; Thyroid Gland ; Thyroid Neoplasms ; Thyroidectomy

BACKGROUND: By development of monoclonal antibodies (MoABs) directed against hematopoietic cells, flow cytometric analysis of bone marrow has become commonplace in clinical hematology laboratories and has a major role in evaluation of lymphohematopoietic malignancies. However, little information about antigen expressions and distribution of normal human bone marrow cells has been published. Therefore, we analysed the immunophenotype of the normal human bone marrow cells to get a normal baseline data for flow cytometric analysis. METHODS: The bone marrow aspirates of 20 healthy donors of allogeneic bone marrow transplantation were analysed using flow cytometry (Becton-Dickinson Co, USA). Seven gated region (R) were set using the forward vs. right angle light scatter (FSC/SSC) cytogram and the percentages of positive cells against 17 monoclonal antibodies were identified in these gated regions by dual parameter flow cytometry. RESULTS: The proportion of total CD45+ cells was 87.57+/-12.82% (mean+/-1SD, n=20) and CD45- (nucleated erythrocytes) cells was 12.43+/-12.82% of all nucleated bone marrow cells. T cells were more numerous than B cells in total gates (P=.0001). T helper/inducer cells (Th) to T suppressor/cytotoxic cells (Ts) ratio was 1.38+/-0.53 and CD4+ cells were distributed in larger size and higher SSC fractions in FSC/SSC cytogram than CD8+ cells (P=.0001). While CD4+, 8+ cells were rarely existed, CD10+ cells were 17.63+/-11.43% of all nucleated bone marrow cells and they mainly distributed in granulocytic fractions. Lymphocytes represent 60% of all lymphogate cells and T cells were mostly mature cells. CD10+ cells and CD34+ cells in the R1 (lymphogate) were 4.37+/-3.07% and 1.78+/-1.25%, respectively. The total CD34+ cells represent 0.88+/-0.5% of all nucleated bone marrow cells and 65% of them were CD34+CD33+ cells. CONCLUSION: These results indicate each subpopulation of normal bone marrow reveals different regional expression from morphological estimation and these normal expressions should be considered in flow cytometric analysis of hematologic disorders.
Antibodies, Monoclonal ; B-Lymphocytes ; Bone Marrow Cells ; Bone Marrow Transplantation ; Bone Marrow* ; Flow Cytometry ; Hematology ; Humans* ; Immunophenotyping* ; Lymphocytes ; T-Lymphocytes ; Tissue Donors

BACKGROUND: This study was desined to determine the efficacy and clincial usefulness of alfentanil and a combined use of alfentanil and esmolol for blunting hemodynamic responses after tracheal intubation in hypertensive patients who needed a rapid sequence induction. METHODS: Group 1 received alfentanil 15microgram/kg and group 2 received alfentanil 15microgram/kg and esmolol 1 mg/kg intravenously. Thiopental sodium 5 mg/kg and succinylcholine 1 mg/kg were used for the induction of anesthesia. Changes in blood pressure and herat rate were measured during intubation and induction of anesthesia with enflurane-N2O-O2 and vecuronium. Rate pressure products (RPP) was calculated and the frequencies of hypertension, hypotension, tachycardia, bradycardia were measured. RESULTS: In group 1, systolic blood pressure increased significantly at 1, 2 minute and decreased significantly at 4, 5, 10, 15 minute compared to base, and diastolic blood pressure increased significantly at 1 minute and decreased significantly at 4, 5, 10 minute. Heart rate increased significantly at 1, 2 minute. In group 2, systolic blood pressure decrease significantly at 3, 4, 5 minute after tracheal intubation compared to base, and diastolic blood pressure increased at 1 minute and decreased at 4, 5, 10, 15 minute. HR did not change significantly (P < 0.05). CONCLUSION: In treated hypertensive patients, the use of a combination of alfentanil 15/kg and esmolol 1 mg/kg is a useful method to attenuate hemodynamic responses after endotracheal intubation and especially for rapid sequence induction.
Alfentanil* ; Anesthesia ; Blood Pressure ; Bradycardia ; Heart Rate ; Hemodynamics* ; Humans ; Hypertension ; Hypotension ; Intubation ; Intubation, Intratracheal* ; Succinylcholine ; Tachycardia ; Thiopental ; Vecuronium Bromide

Prader-Willi syndrome (PWS) is a complex, multisystem disorder comprising congenital hypotonia, feeding difficulties, hypogonadism and hypogenitalism, short stature, small hands and feet, mental and psychomotor retardation, distinctive facial appearance, onset of obesity in early childhood and a tendency to develop glucose intolerance in adolescence. Yet the syndrome remains difficult to diagnose due to the subtle nature of many of the manifestations. We report an 19-year old man with PWS, confirmed by fluorescence in situ hybridization (FISH) with DNA probes specific for the PWS region on chromosome 15.
Adolescent ; Chromosomes, Human, Pair 15 ; Cryptorchidism* ; DNA Probes ; Fluorescence ; Foot ; Glucose Intolerance ; Hand ; Humans ; Hypogonadism ; In Situ Hybridization ; Male ; Muscle Hypotonia ; Obesity ; Prader-Willi Syndrome* ; Young Adult

Secondary hyperparathyroidism is the condition which leads to excessive production of the parathyroid hormone secreted to compensate for longstanding hypocalcemia in chronic renal failure. After restoration of normal renal function, some patients continue to have autonomous parathyroid hyperfunction. In 1963 St. Goar termed it tertiary hyperparathyroidism. Hyperparathyroidism in the chronic renal failure is mostly well managed medically, but sometimes may require surgical intervention in refractory hyperparathyroidism. Recently, we have experienced a female patient diagnosed as tertiary hyperparathyroidism with persistent hypercalcemia after renal transplantation and report the results of subtotal parathyroidectomy and thyroid right lobectomy due to hyperparathyroidism and thyroid papillary carcinoma found coincidentally.
Carcinoma, Papillary* ; Female ; Humans ; Hypercalcemia ; Hyperparathyroidism* ; Hyperparathyroidism, Secondary ; Hypocalcemia ; Kidney Failure, Chronic ; Kidney Transplantation ; Parathyroid Hormone ; Parathyroidectomy ; Thyroid Gland*

The Korean Society for the Study of Obesity (KSSO) has defined the waist circumference cutoff value of central obesity as 90 cm for men and 85 cm for women. The purpose of this investigation was to determine the corresponding waist circumference values. A total of 3,508 persons in the Korean Rural Genomic Cohort Study were enrolled in this survey. Receiver operating characteristic (ROC) curve analysis was used to find appropriate waist circumference cutoff values in relation to insulin resistance determined by homeostasis model assessment for insulin resistance (HOMA-IR), body mass index (BMI), and components of metabolic syndrome. The optimal waist circumference cutoff values were 87 cm for men and 83 cm for women by ROC analysis to HOMA-IR and 86 cm for men and 83 cm for women by ROC analysis to value with more than two components of metaobolic syndrome. By using a BMI > or =25 kg/m2, 86 cm for men and 82 cm for women were optimal waist circumference cutoff values. In this study, we suggest that the most reasonable waist circumference cutoff values are 86-87 cm for men and 82-83 cm for women.
Cohort Studies ; Diagnosis, Computer-Assisted/*methods ; Female ; *Health Status Indicators ; Humans ; Korea/epidemiology ; Male ; Metabolic Syndrome X/*diagnosis/*epidemiology ; Middle Aged ; Physical Examination/methods/statistics & numerical data ; Prevalence ; Reproducibility of Results ; Risk Assessment/methods ; Risk Factors ; Rural Population/*statistics & numerical data ; Sensitivity and Specificity ; *Waist Circumference

PURPOSE: The short insulin tolerance test is a simple and reliable method of estimating insulin sensitivity. This study was designed to compare the insulin sensitizing effects of thiazolidinediones (TZDs) on the degree of insulin resistance, determined by a short insulin tolerance test (Kitt) in type 2 diabetic patients. PATIENTS AND METHODS: Eighty-three subjects (mean age = 57.87 +/- 10.78) with type 2 diabetes mellitus were enrolled and received daily one dose of rosiglitazone (4mg) or pioglitazone (15mg). The mean follow-up duration was 25.39 +/- 9.66 months. We assessed insulin sensitivity using HOMA-IR and the short insulin tolerance test before and after TZDs treatment. RESULTS: When we compared patients' characteristics before and after TZDs treatment, the mean fasting glucose level was significantly decreased (183.27 +/- 55.04 to 137.35 +/- 36.42mg/dL, p < 0.001) and the mean HbA1C level was significantly decreased (9.24 +/- 1.96 to 8.11 +/- 1.39%, p < 0.001). Also, Kitt values were significantly increased (2.03 +/- 1.14 to 2.67 +/- 0.97%/min, p = 0.003), whereas HOMA-IR was significantly decreased (2.98 +/- 0.68 to 1.04 +/- 0.24, p < 0.05). When classifying insulin resistance by Kitt values, insulin resistant subjects' values were increased (< 2.5%/min; 1.51 +/- 0.53%/min to 2.63 +/- 0.88, p < 0.001), whereas the values decreased in insulin sensitive subjects (> or = 2.5%/min; 3.50 +/- 0.75%/min to 2.75 +/- 1.12%/min, p = 0.002). CONCLUSION: The glucose lowering effects of TZDs by improving insulin resistance could be determined by using Kitt. However, Kitt may be a beneficial tool to determine TZDs' effects only when patients' Kitt values are less than 2.5%/min.
Aged ; Blood Glucose/metabolism ; Diabetes Mellitus, Type 2/blood/*diagnosis/*drug therapy ; Drug Tolerance ; Female ; Humans ; Hypoglycemic Agents/therapeutic use ; Insulin/diagnostic use ; *Insulin Resistance ; Male ; Middle Aged ; Thiazolidinediones/*therapeutic use